Advanced search
Publication Cover
Annals of Medicine Volume 50, 2018 - Issue 6
Submit an article Journal homepage
1,936
Views
22
CrossRef citations to date
0
Altmetric
Review Article

Lipid lowering drugs and inflammatory changes: an impact on cardiovascular outcomes?

M. RuscicaDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-0195-7061View further author information
ORCID Icon,
N. FerriDipartimento di Scienze del Farmaco, Università degli Studi di Padova, Padova, Italy; ORCID Iconhttp://orcid.org/0000-0001-8898-7441View further author information
ORCID Icon,
C. MacchiDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy; ORCID Iconhttp://orcid.org/0000-0002-5919-989XView further author information
ORCID Icon,
A. CorsiniDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy; ORCID Iconhttp://orcid.org/0000-0002-9912-9482View further author information
ORCID Icon &
C. R. SirtoriCentro Dislipidemie, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, ItalyView further author information
Pages 461-484 | Received 20 May 2018, Accepted 30 Jun 2018, Published online: 15 Oct 2018

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Amr Ali, Yuehong Wang, Lingyun Wu & Guangdong Yang. (2021) Gasotransmitter signaling in energy homeostasis and metabolic disorders. Free Radical Research 55:1, pages 83-105.
Read now
M. Ruscica, M. Banach, A. Sahebkar, A. Corsini & C. R. Sirtori. (2019) ETC-1002 (Bempedoic acid) for the management of hyperlipidemia: from preclinical studies to phase 3 trials. Expert Opinion on Pharmacotherapy 20:7, pages 791-803.
Read now

Articles from other publishers (20)

Michael Mallin, Jane Hall, Maria Herlihy, Eduard J. Gelman & Michael B. Stone. (2023) A pilot retrospective study of a physician-directed and genomics-based model for precision lifestyle medicine. Frontiers in Medicine 10.
Crossref
Yanan Wang, Dan Fang, Qinzhi Yang, Jingcan You, Liqun Wang, Jianbo Wu, Min Zeng & Mao Luo. (2023) Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis. Frontiers in Immunology 14.
Crossref
Gianni Biolo, Pierandrea Vinci, Alessandro Mangogna, Matteo Landolfo, Paolo Schincariol, Nicola Fiotti, Filippo Mearelli & Filippo Giorgio Di Girolamo. (2022) Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome. Frontiers in Cardiovascular Medicine 9.
Crossref
Chengyu Liu, Wanyao Yan, Jiajian Shi, Shun Wang, Anlin Peng, Yuchen Chen & Kun Huang. (2022) Biological Actions, Implications, and Cautions of Statins Therapy in COVID-19. Frontiers in Nutrition 9.
Crossref
Dejan Reljic, Walburga Dieterich, Hans J. Herrmann, Markus F. Neurath & Yurdagül Zopf. (2022) “HIIT the Inflammation”: Comparative Effects of Low-Volume Interval Training and Resistance Exercises on Inflammatory Indices in Obese Metabolic Syndrome Patients Undergoing Caloric Restriction. Nutrients 14:10, pages 1996.
Crossref
Brett D. M. Jones, Salman Farooqui, Stefan Kloiber, Muhammad Omair Husain, Benoit H. Mulsant & Muhammad Ishrat Husain. (2021) Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence. Life 11:8, pages 819.
Crossref
Klaus-Dieter Schlüter, Annemarie Wolf & Rolf Schreckenberg. (2020) Coming Back to Physiology: Extra Hepatic Functions of Proprotein Convertase Subtilisin/Kexin Type 9. Frontiers in Physiology 11.
Crossref
Yuyu Chou, Jin Ma, Xin Su & Yong Zhong. (2020) Emerging insights into the relationship between hyperlipidemia and the risk of diabetic retinopathy. Lipids in Health and Disease 19:1.
Crossref
Tiziana Sampietro, Francesco Sbrana, Federico Bigazzi, Andrea Ripoli & Beatrice Dal Pino. (2020) Null receptor homozygous familial hypercholesterolaemia: Quoad valetudinem long life treatment . European Journal of Preventive Cardiology 27:19, pages 2105-2108.
Crossref
Yingjian Deng, Guiyang Li, Dong Chang & Xin Su. (2020) YKL-40 as a novel biomarker in cardio-metabolic disorders and inflammatory diseases. Clinica Chimica Acta 511, pages 40-46.
Crossref
Corbin A. Shields, Bibek Poudel, Kasi C. McPherson, Andrea K. Brown, Ubong S. Ekperikpe, Evan Browning, Lamari Sutton, Denise C. Cornelius & Jan M. Williams. (2020) Treatment With Gemfibrozil Prevents the Progression of Chronic Kidney Disease in Obese Dahl Salt-Sensitive Rats. Frontiers in Physiology 11.
Crossref
Massimiliano Ruscica, Alberto Corsini, Nicola Ferri, Maciej Banach & Cesare R. Sirtori. (2020) Clinical approach to the inflammatory etiology of cardiovascular diseases. Pharmacological Research 159, pages 104916.
Crossref
Nicola Ferri & Alberto Corsini. (2020) Clinical Pharmacology of Statins: an Update. Current Atherosclerosis Reports 22:7.
Crossref
Željko Reiner, Cesare R. Sirtori, Maciej Banach, Massimiliano Ruscica & Amirhossein Sahebkar. (2019) Methotrexate for Cardiovascular Risk Reduction: The Right Choice?. Angiology 71:2, pages 105-107.
Crossref
Massimiliano Ruscica, Marco Busnelli, Enrico Runfola, Alberto Corsini & Cesare R. Sirtori. (2019) Impact of PPAR-Alpha Polymorphisms—The Case of Metabolic Disorders and Atherosclerosis. International Journal of Molecular Sciences 20:18, pages 4378.
Crossref
Massimiliano Ruscica, Lale Tokgözoğlu, Alberto Corsini & Cesare R. Sirtori. (2019) PCSK9 inhibition and inflammation: A narrative review. Atherosclerosis 288, pages 146-155.
Crossref
C Macchi, M Banach, A Corsini, CR Sirtori, N Ferri & M Ruscica. (2019) Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents. European Journal of Preventive Cardiology 26:9, pages 930-949.
Crossref
Françoise Wilhelmi de Toledo, Franziska Grundler, Audrey Bergouignan, Stefan Drinda & Andreas Michalsen. (2019) Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. PLOS ONE 14:1, pages e0209353.
Crossref
Maria G Zenti, Anna Altomari, Maria G Lupo, Margherita Botta, Enzo Bonora, Alberto Corsini, Massimiliano Ruscica & Nicola Ferri. (2018) From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients. European Journal of Preventive Cardiology 25:17, pages 1843-1851.
Crossref
Rosa Vona, Lucrezia Gambardella & Elisabetta Straface. 2018. Carotid Artery - Gender and Health [Working Title]. Carotid Artery - Gender and Health [Working Title].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.